Global and China Prophylactic Human Vaccines Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Prophylactic Human Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • MedImmune

    • Serum Institute of India

    • Bharat Biotech International

    • Takeda Pharmaceutical Company

    • Seqirus

    • Merck

    • Pfizer

    • Shanghai BravoBio

    • Altimmune

    • SK Chemicals

    • Bavarian Nordic

    • ALK

    • Sanofi Pasteur

    • GlaxoSmithKline

    • Hualan Biological Engineering

    • Zydus Cadila

    • BiondVax Pharmaceuticals

    • Janssen Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Type I

    • Type II

    Application:

    • Pediatric Prophylactic Vaccines

    • Adult Prophylactic Vaccines

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prophylactic Human Vaccines Industry Overview

      • 1.1.1 Prophylactic Human Vaccines Market Scope and Market Segments

      • 1.1.2 Prophylactic Human Vaccines Industry Characteristics

      • 1.1.3 Global and China Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prophylactic Human Vaccines Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prophylactic Human Vaccines Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Type I

      • 1.2.2 Type II

    • 1.3 Global Prophylactic Human Vaccines Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Pediatric Prophylactic Vaccines

      • 1.3.2 Adult Prophylactic Vaccines

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prophylactic Human Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prophylactic Human Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prophylactic Human Vaccines Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prophylactic Human Vaccines Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prophylactic Human Vaccines Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prophylactic Human Vaccines Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prophylactic Human Vaccines Industry PEST Analysis

    • 2.3 Prophylactic Human Vaccines Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prophylactic Human Vaccines Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prophylactic Human Vaccines Industry

    Chapter 3 Global and China Prophylactic Human Vaccines Market, by Manufacturer

    • 3.1 Global and China Prophylactic Human Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prophylactic Human Vaccines Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prophylactic Human Vaccines Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prophylactic Human Vaccines Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prophylactic Human Vaccines Market Top 3 Players

    Chapter 4 Global and China Prophylactic Human Vaccines Market, by Type (2017-2028)

    • 4.1 Prophylactic Human Vaccines Market Trend, by Type

    • 4.2 Global Prophylactic Human Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prophylactic Human Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prophylactic Human Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prophylactic Human Vaccines Price Trend, by Type (2017-2028)

    • 4.3 China Prophylactic Human Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prophylactic Human Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prophylactic Human Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prophylactic Human Vaccines Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prophylactic Human Vaccines Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prophylactic Human Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prophylactic Human Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prophylactic Human Vaccines Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prophylactic Human Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prophylactic Human Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prophylactic Human Vaccines Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prophylactic Human Vaccines Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prophylactic Human Vaccines Market Analysis

    • 7.1 North America Prophylactic Human Vaccines Market, by Type

    • 7.2 North America Prophylactic Human Vaccines Market, by Application

    • 7.3 North America Prophylactic Human Vaccines Market Analysis and Forecast, by Country

      • 7.3.1 United States Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prophylactic Human Vaccines Market Analysis

    • 8.1 Europe Prophylactic Human Vaccines Market, by Type

    • 8.2 Europe Prophylactic Human Vaccines Market, by Application

    • 8.3 Europe Prophylactic Human Vaccines Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prophylactic Human Vaccines Market Analysis

    • 9.1 APAC Prophylactic Human Vaccines Market, by Type

    • 9.2 APAC Prophylactic Human Vaccines Market, by Application

    • 9.3 APAC Prophylactic Human Vaccines Market Analysis and Forecast, by Country

      • 9.3.1 China Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prophylactic Human Vaccines Market Analysis

    • 10.1 Latin America, Middle East and Africa Prophylactic Human Vaccines Market, by Type

    • 10.2 Latin America, Middle East and Africa Prophylactic Human Vaccines Market, by Application

    • 10.3 Latin America, Middle East and Africa Prophylactic Human Vaccines Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prophylactic Human Vaccines Company Profiles

      • 11.1 MedImmune

        • 11.1.1 MedImmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 MedImmune Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.1.3 MedImmune Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Serum Institute of India

        • 11.2.1 Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Serum Institute of India Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.2.3 Serum Institute of India Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Bharat Biotech International

        • 11.3.1 Bharat Biotech International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Bharat Biotech International Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.3.3 Bharat Biotech International Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Takeda Pharmaceutical Company

        • 11.4.1 Takeda Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Takeda Pharmaceutical Company Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.4.3 Takeda Pharmaceutical Company Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Seqirus

        • 11.5.1 Seqirus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Seqirus Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.5.3 Seqirus Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Merck

        • 11.6.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Merck Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.6.3 Merck Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer

        • 11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.7.3 Pfizer Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Shanghai BravoBio

        • 11.8.1 Shanghai BravoBio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Shanghai BravoBio Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.8.3 Shanghai BravoBio Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Altimmune

        • 11.9.1 Altimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Altimmune Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.9.3 Altimmune Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 SK Chemicals

        • 11.10.1 SK Chemicals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 SK Chemicals Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.10.3 SK Chemicals Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Bavarian Nordic

        • 11.11.1 Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Bavarian Nordic Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.11.3 Bavarian Nordic Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 ALK

        • 11.12.1 ALK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 ALK Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.12.3 ALK Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Sanofi Pasteur

        • 11.13.1 Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Sanofi Pasteur Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.13.3 Sanofi Pasteur Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 GlaxoSmithKline

        • 11.14.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 GlaxoSmithKline Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.14.3 GlaxoSmithKline Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Hualan Biological Engineering

        • 11.15.1 Hualan Biological Engineering Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Hualan Biological Engineering Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.15.3 Hualan Biological Engineering Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Zydus Cadila

        • 11.16.1 Zydus Cadila Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Zydus Cadila Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.16.3 Zydus Cadila Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 BiondVax Pharmaceuticals

        • 11.17.1 BiondVax Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 BiondVax Pharmaceuticals Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.17.3 BiondVax Pharmaceuticals Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Janssen Pharmaceuticals

        • 11.18.1 Janssen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Janssen Pharmaceuticals Prophylactic Human Vaccines Product Profiles, Application and Specification

        • 11.18.3 Janssen Pharmaceuticals Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prophylactic Human Vaccines Industry Investment Prospect and Risk Assessment

    • 12.1 Prophylactic Human Vaccines Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prophylactic Human Vaccines Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prophylactic Human Vaccines Production Value and Growth Rate (2017-2028)

    • Figure China Prophylactic Human Vaccines Production Value and Growth Rate (2017-2028)

    • Figure Global Prophylactic Human Vaccines Market Size and Growth Rate of Type I (2017-2028)

    • Figure Global Prophylactic Human Vaccines Market Size and Growth Rate of Type II (2017-2028)

    • Figure Global Prophylactic Human Vaccines Market Size and Growth Rate of Pediatric Prophylactic Vaccines (2017-2028)

    • Figure Global Prophylactic Human Vaccines Market Size and Growth Rate of Adult Prophylactic Vaccines (2017-2028)

    • Figure North America Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prophylactic Human Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prophylactic Human Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prophylactic Human Vaccines Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prophylactic Human Vaccines Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prophylactic Human Vaccines Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prophylactic Human Vaccines Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prophylactic Human Vaccines Market Share, by Manufacturer in 2021

    • Figure Global and China Prophylactic Human Vaccines Market Share, by Manufacturer in 2022

    • Table Global Prophylactic Human Vaccines Sales Volume, by Type (2017-2028)

    • Table Global Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Global Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Global Prophylactic Human Vaccines Sales Value, by Type (2017-2028)

    • Table Global Prophylactic Human Vaccines Sales Value Share, by Type (2017-2028)

    • Figure Global Prophylactic Human Vaccines Price Trend, by Type (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Volume, by Type (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure China Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Value, by Type (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Value Share, by Type (2017-2028)

    • Figure China Prophylactic Human Vaccines Price Trend, by Type (2017-2028)

    • Table Global Prophylactic Human Vaccines Sales Volume, by Application (2017-2028)

    • Table Global Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Global Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Table Global Prophylactic Human Vaccines Sales Value, by Application (2017-2028)

    • Table Global Prophylactic Human Vaccines Sales Value Share, by Application (2017-2028)

    • Figure Global Prophylactic Human Vaccines Sales Value Share, by Application (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Volume, by Application (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Value, by Application (2017-2028)

    • Table China Prophylactic Human Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Prophylactic Human Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prophylactic Human Vaccines Production, Import, Consumption and Export (2017-2022)

    • Table North America Prophylactic Human Vaccines Sales Volume, by Type (2017-2028)

    • Table North America Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure North America Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Table North America Prophylactic Human Vaccines Sales Volume, by Application (2017-2028)

    • Table North America Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure North America Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure United States Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Europe Prophylactic Human Vaccines Sales Volume, by Type (2017-2028)

    • Table Europe Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Europe Prophylactic Human Vaccines Sales Volume, by Application (2017-2028)

    • Table Europe Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure UK Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure France Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure France Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Table APAC Prophylactic Human Vaccines Sales Volume, by Type (2017-2028)

    • Table APAC Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Table APAC Prophylactic Human Vaccines Sales Volume, by Application (2017-2028)

    • Table APAC Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure India Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure India Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prophylactic Human Vaccines Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prophylactic Human Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prophylactic Human Vaccines Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prophylactic Human Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prophylactic Human Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prophylactic Human Vaccines Sales Value and Growth Rate (2017-2028)

    • Table MedImmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MedImmune Product Profiles, Application and Specification

    • Table MedImmune Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute of India Product Profiles, Application and Specification

    • Table Serum Institute of India Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bharat Biotech International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bharat Biotech International Product Profiles, Application and Specification

    • Table Bharat Biotech International Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Company Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Company Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Seqirus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Seqirus Product Profiles, Application and Specification

    • Table Seqirus Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shanghai BravoBio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shanghai BravoBio Product Profiles, Application and Specification

    • Table Shanghai BravoBio Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Altimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Altimmune Product Profiles, Application and Specification

    • Table Altimmune Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table SK Chemicals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SK Chemicals Product Profiles, Application and Specification

    • Table SK Chemicals Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bavarian Nordic Product Profiles, Application and Specification

    • Table Bavarian Nordic Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ALK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ALK Product Profiles, Application and Specification

    • Table ALK Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur Product Profiles, Application and Specification

    • Table Sanofi Pasteur Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hualan Biological Engineering Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hualan Biological Engineering Product Profiles, Application and Specification

    • Table Hualan Biological Engineering Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zydus Cadila Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zydus Cadila Product Profiles, Application and Specification

    • Table Zydus Cadila Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BiondVax Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BiondVax Pharmaceuticals Product Profiles, Application and Specification

    • Table BiondVax Pharmaceuticals Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Janssen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Janssen Pharmaceuticals Product Profiles, Application and Specification

    • Table Janssen Pharmaceuticals Prophylactic Human Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.